NASDAQ:CRVS | EBITDA | Corvus Pharmaceuticals, Inc.

Complete source-backed ebitda history.

Available history
2015-12-31 to 2026-03-31
Data captured

Historical EBITDA

DateEBITDA
2026-03-31-$14.85M
2025-12-31-$12.19M
2025-03-31-$9.9M
2024-12-31-$8.09M
2024-03-31-$6.23M
2023-12-31-$5.62M
2023-03-31-$6.52M
2022-12-31-$5.57M
2022-03-31-$7.33M
2021-12-31-$6.72M
2021-03-31-$11.35M
2020-12-31-$9.74M
2020-03-31-$13.09M
2019-12-31-$11.26M
2019-03-31-$12.12M
2018-12-31-$10.99M
2018-03-31-$14.43M
2017-12-31-$11.97M
2017-03-31-$16.01M

Annual EBITDA

DateEBITDA
2025-12-31-$42.87M
2024-12-31-$27.46M
2023-12-31-$23.26M
2022-12-31-$32.2M
2021-12-31-$38.17M
2020-12-31-$43.13M
2019-12-31-$48.11M
2018-12-31-$48.38M
2017-12-31-$55.68M
2016-12-31-$36.38M
2015-12-31-$13.62M